Skip to main content

Advertisement

Open Peer Review Reports for: Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
11 Oct 2017 Submitted Original manuscript
22 Jan 2018 Author responded Author comments - Yoshihiko Tomita
Resubmission - Version 2
22 Jan 2018 Submitted Manuscript version 2
3 May 2018 Reviewed Reviewer Report - Giuseppe Procopio
30 May 2018 Reviewed Reviewer Report - Ian Davis
8 Sep 2018 Reviewed Reviewer Report - Reviewer 2
8 Oct 2018 Author responded Author comments - Yoshihiko Tomita
Resubmission - Version 3
8 Oct 2018 Submitted Manuscript version 3
11 Oct 2018 Reviewed Reviewer Report - Ian Davis
11 Dec 2018 Author responded Author comments - Yoshihiko Tomita
Resubmission - Version 4
11 Dec 2018 Submitted Manuscript version 4
Publishing
13 Dec 2018 Editorially accepted
7 Jan 2019 Article published 10.1186/s12885-018-5224-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement